|
1
|
Marioni G, Marchese-Ragona R, Cartei G,
Marchese F and Staffieri A: Current opinion in diagnosis and
treatment of laryngeal carcinoma. Cancer Treat Rev. 32:504–515.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Papadas TA, Alexopoulos EC, Mallis A,
Jelastopulu E, Mastronikolis NS and Goumas P: Survival after
laryngectomy: a review of 133 patients with laryngeal carcinoma.
Eur Arch Otorhinolaryngol. 267:1095–1101. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sun YN, Liu M, Yang B, Li B and Lu J: Role
of siRNA silencing of MMP-2 gene on invasion and growth of
laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol.
265:1385–1391. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhao JX and Xie XL: Regulation of gene
expression in laryngeal carcinama by microRNAs. Int J Pathol Clin
Med. 32:222–225. 2012.
|
|
5
|
Srivastava R: Apoptosis, Cell Signaling,
and Human Diseases Molecular Mechanisms. 1. Humana Press; Totowa:
2007
|
|
6
|
Bea S, Tort F, Pinyol M, et al: BMI-1 gene
amplification and overexpression in hematological malignancies
occur mainly in mantle cell lymphomas. Cancer Res. 61:2409–2412.
2001.
|
|
7
|
Bhattacharyya J, Mihara K, Ohtsubo M, et
al: Overexpression of BMI-1 correlates with drug resistance in
B-cell lymphoma cells through the stabilization of survivin
expression. Cancer Sci. 103:34–41. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sawa M, Yamamoto K, Yokozawa T, et al:
BMI-1 is highly expressed in M0-subtype acute myeloid leukemia. Int
J Hematol. 82:42–47. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kimura M, Takenobu H, Akita N, et al: Bmi1
regulates cell fate via tumor suppressor WWOX repression in
small-cell lung cancer cells. Cancer Sci. 102:983–990. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim JH, Yoon SY, Kim CN, et al: The Bmi-1
oncoprotein is overexpressed in human colorectal cancer and
correlates with the reduced p16INK4a/p14ARF proteins. Cancer Lett.
203:217–224. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Glinsky GV, Berezovska O and Glinskii AB:
Microarray analysis identifies a death-from-cancer signature
predicting therapy failure in patients with multiple types of
cancer. J Clin Invest. 115:1503–1521. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Song W, Tao K, Li H, et al: Bmi1 is
related to proliferation, survival and poor prognosis in pancreatic
cancer. Cancer Sci. 101:1754–1760. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yao X, Wang X, Zhang S and Zhu H: Effects
of Bmi-1 RNAi gene on laryngeal carcinoma Hep-2 cells. Lin Chung Er
Bi Yan Hou Tou Jing Wai Ke Za Zhi. 26:550–557. 2012.(In
Chinese).
|
|
14
|
Kang MK, Kim RH, Kim SJ, et al: Elevated
Bmi-1 expression is associated with dysplastic cell transformation
during oral carcinogenesis and is required for cancer cell
replication and survival. Br J Cancer. 96:126–133. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Song LB, Zeng MS, Liao WT, et al: Bmi-1 is
a novel molecular marker of nasopharyngeal carcinoma progression
and immortalizes primary human nasopharyngeal epithelial cells.
Cancer Res. 66:6225–6232. 2006. View Article : Google Scholar
|
|
16
|
Glinsky GV: Death-from-cancer signatures
and stem cell contribution to metastatic cancer. Cell Cycle.
4:1171–1175. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hoenerhoff MJ, Chu I, Barkan D, et al:
BMI1 cooperates with H-RAS to induce an aggressive breast cancer
phenotype with brain metastases. Oncogene. 28:3022–3032. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu CR, Lee SS, Ho C, et al: Bmi1 functions
as an oncogene independent of Ink4A/Arf repression in hepatic
carcinogenesis. Mol Cancer Res. 7:1937–1945. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Elbashir SM, Harborth J, Lendeckel W, et
al: Duplexes of 21-nucleotide RNAs mediate RNA interference in
cultured mammalian cells. Nature. 411:494–498. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mittal V: Improving the efficiency of RNA
interference in mammals. Nat Rev Genet. 5:355–365. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Moffat J and Sabatini DM: Building
mammalian signalling pathways with RNAi screens. Nat Rev Mol Cell
Biol. 7:177–187. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim DH and Rossi JJ: Strategies for
silencing human diseaseusing RNA interference. Nat Rev Genet.
8:173–184. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang XZ and Wang JB: Practical
otolaryngology. People’s Medical Publishing House; Beijing: pp.
502–503. 1998
|
|
24
|
Tu Gy, Tang PZ and Jia CY:
Horizontovertical laryngectomy for supraglottic carcinoma.
Otolaryngol Head Neck Surg. 117:280–286. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sessions DG, Lenox J, Spector GJ, et al:
Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
Laryngoscope. 112:1281–1288. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu YZ, Tang PZ, Qi YF and Xu Z: The
management of stomal recurrence after laryngectomy. Zhonghua Er Bi
Yan Hou Ke Za Zhi. 37:380–383. 2002.(In Chinese).
|
|
27
|
Ringrose L and Paro R: Epigenetic
regulation of cellular memory by the Polycomb and Trithorax group
proteins. Annu Rev Genet. 38:413–443. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Raaphorst FM: Deregulated expression of
Polycomb-group oncogenes in human malignant lymphomas and
epithelial tumors. Hum Mol Genet. 14:R93–R100. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kikuchi J, Kinoshita I, Shimizu Y, et al:
Distinctive expression of the polycomb group proteins Bmi1 polycomb
ring finger oncogene and enhancer of zeste homolog 2 in nonsmall
cell lung cancers and their clinical and clinicopathologic
significance. Cancer. 116:3015–3024. 2010. View Article : Google Scholar
|
|
30
|
Yao XB, Wang XX, Zhang SQ, Yan LY and Zhu
HL: Association of Bmi-1 mRNA overexpression with differentiation,
metastasis and prognosis of laryngocarcinoma. Xi’An Jiaotong Daxue
Xuebao. 32:246–249. 2011.(In Chinese).
|
|
31
|
Wang YX, Wei YM, Wang XH and Zhu XY:
Construction of eukaryotic expression vector targeting Bmi-1 and
its influences on proliferation of SW480 cells. Xian Dai Sheng Wu
Yi Xue Jin Zhan. 9:2270–2272. 2009.(In Chinese).
|
|
32
|
Wang ZX, Lu BB, Yang JS, Wang KM and De W:
Adenovirus-mediated siRNA targeting c-Met inhibits proliferation
and invasion of small-cell lung cancer (SCLC) cells. J Surg Res.
171:127–135. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li PH, Wang HJ, Liu W and Xu XG: PRDM1
gene expression in laryngeal carcinoma and its clinical
significance. Head Neck Surg. 24:179–180. 2010.
|
|
34
|
Pirrotta V: Polycombing the genome: PcG,
trxG, and chromatin silencing. Cell. 93:333–336. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Orlando V: Polycomb, epigenomes, and
control of cell identity. Cell. 112:599–606. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jacobs JJ, Kieboom K, Marino S, Depinho RA
and van Lohuizen M: The oncogene and Polycomb-group gene bmi-1
regulates cell proliferation and senescence through the ink4a
locus. Nature. 397:164–168. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
Itahana K, Zou Y, Itahana Y, et al:
Control of the replicative life span of human fibroblasts by p16
and the polycomb protein Bmi-1. Mol Cell Biol. 23:389–401. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dimri GP: What has senescence got to do
with cancer? Cancer Cell. 7:505–512. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xu Z, Liu H, Lv X, Liu Y, Li S and Li H:
Knockdown of the Bmi-1 oncogene inhibits cell proliferation and
induces cell apoptosis and is involved in the decrease of Akt
phosphorylation in the human breast carcinoma cell line MCF-7.
Oncol Rep. 25:409–418. 2011.PubMed/NCBI
|
|
40
|
Liu WL, Guo XZ, Zhang LJ, et al:
Prognostic relevance of Bmi-1 expression and autoantibodies in
esophageal squamous cell carcinoma. BMC Cancer. 10:4672010.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Abdouh M, Facchino S, Chatoo W, et al:
BMI1 sustains human glioblastoma multiforme stem cell renewal. J
Neurosci. 29:8884–8896. 2009. View Article : Google Scholar : PubMed/NCBI
|
